Related Experiment Video
Updated: Nov 20, 2025

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
Inflammaging as a link between autoimmunity and cardiovascular disease: the case of rheumatoid arthritis
Pedro Santos-Moreno1, Gabriel Burgos-Angulo2, Maria Alejandra Martinez-Ceballos3
1Rheumatology, Biomab IPS, Bogota, Colombia pedrosantosmoreno@hotmail.com.
Insights
Individuals with autoimmune diseases experience accelerated vascular aging due to chronic inflammation, increasing cardiovascular disease risk. Treatments for rheumatoid arthritis show cardiovascular benefits, suggesting new therapeutic avenues.
Area of Science:
- Cardiovascular Disease Research
- Immunology
- Gerontology
Background:
- Cardiovascular disease (CVD) risk factors include age and inflammation.
- Inflammaging describes age-related chronic inflammation, accelerating vascular remodeling and atherogenesis.
- Autoimmune diseases involve chronic inflammation, potentially leading to premature vascular aging.
Purpose of the Study:
- To explore the link between autoimmune diseases and accelerated vascular aging.
- To investigate the impact of autoimmunity on cardiovascular health.
- To assess the cardiovascular benefits of rheumatoid arthritis treatments.
Main Methods:
- Review of traditional and non-traditional CVD risk factors.
- Analysis of the role of inflammation and inflammaging in vascular aging.
- Evaluation of non-invasive cardiovascular tests like pulse wave velocity.
- Examination of treatment impacts on rheumatoid arthritis patients' cardiovascular health.
Main Results:
- Autoimmune diseases are associated with accelerated vascular aging and increased CVD risk.
- Chronic inflammation in autoimmunity contributes to vascular stiffness.
- Rheumatoid arthritis treatments demonstrate positive cardiovascular effects.
Conclusions:
- Autoimmunity accelerates vascular aging, increasing cardiovascular morbidity and mortality.
- Targeting inflammation in autoimmune diseases may mitigate cardiovascular risks.
- Pharmacotherapy for rheumatoid arthritis offers potential cardiovascular benefits.
Abstract:
Currently, traditional and non-traditional risk factors for cardiovascular disease have been established. The first group includes age, which constitutes one of the most important factors in the development of chronic diseases. The second group includes inflammation, the pathophysiology of which contributes to an accelerated process of vascular remodelling and atherogenesis in autoimmune diseases. Indeed, the term inflammaging has been used to refer to the inflammatory origin of ageing, explicitly due to the chronic inflammatory process associated with age (in healthy individuals). Taking this into account, it can be inferred that people with autoimmune diseases are likely to have an early acceleration of vascular ageing (vascular stiffness) as evidenced in the alteration of non-invasive cardiovascular tests such as pulse wave velocity. Thus, an association is created between autoimmunity and high morbidity and mortality rates caused by cardiovascular disease in this population group. The beneficial impact of the treatments for rheumatoid arthritis at the cardiovascular level has been reported, opening new opportunities for pharmacotherapy.
More Related Videos
09:18Author Spotlight: Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue
Published on: February 24, 2023
04:50Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Inflammation
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
The JAK-STAT Signaling Pathway
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Inflammatory Response I: Vascular and Cellular